secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2025-08-06T23:59:59+00:00
Accession:  0001731122-25-001076
Event type: regulatory
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Renovaro receives Nasdaq non-compliance notice for annual meeting; granted extension to Oct 31, 2025
--------------------------------------------------------------------------------

- Received Nasdaq notice on July 7, 2025 for failure to comply with Listing Rule 5620(a) requiring annual shareholder meeting.
- Nasdaq accepted compliance plan on August 5, 2025 and granted extension until October 31, 2025 to hold meeting.
- Company intends to hold annual meeting within the extension period to regain compliance with listing standards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112225001076/0001731122-25-001076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112225001076/e6758_8k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-25-001076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer